Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 954 clinical trials
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) (GP)

The purposes of this study are: to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.

  • 0 views
  • 01 Feb, 2024
  • 1 location
Clinical Study on Raman Spectra of Blood Saliva and Urine in Patients With Cancer Treated by Modern Therapy

Blood, saliva and urine samples of tumor patients on the day of admission and discharge were collected for Raman spectral analysis, which provided exploration for the prediction of efficacy, follow-up and prognosis according to the variation characteristics of Raman spectral.

cancer
targeted therapy
  • 0 views
  • 16 Feb, 2024
  • 1 location
Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System

It is planned to integrate various services based on computer vision technologies for analysis of the certain type of x-ray study into Moscow Unified Radiological Information Service (hereinafter referred to as URIS). As a result of using computer vision-based services, it is expected: Reducing the number of false negative and …

cancer
x-rays
lung cancer
ct scan
chest x-ray
  • 0 views
  • 05 Aug, 2020
Application of Serial Body Composition Change for Risk Prediction in Treating Patients With Severe Pneumonia

We hypothesize that serial changes of body composition in patients with pneumonia can help clinician to monitor prognosis. It was associated with underlying immune response.

pneumonia
  • 0 views
  • 16 Feb, 2024
  • 1 location
Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children

This study will evaluate the persistence of immunogenicity following a reduced dosing schedule of 10- or 13-valent Pneumococcal Conjugate Vaccine (PCV10, PCV13). This is the follow-up of a randomized controlled trial in which children received a single priming dose of PCV10 or PCV13 (at 6 or 14 weeks of age) …

pneumococcal conjugate
conjugate vaccine
booster
pneumococcal
vaccination
  • 0 views
  • 16 Feb, 2024
  • 1 location
Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants

To determine the optimal EGFR TKIs treatment strategies for lung adenocarcinoma harboring EGFR exon 19 deletion variants

  • 0 views
  • 05 Aug, 2020
Predictors of Severe COVID-19 Outcomes

This is a longitudinal, multi-center, observational study collecting diverse biological measurements and clinical and epidemiological data for the purpose of enabling a greater understanding of the onset of severe outcomes, primarily acute respiratory distress syndrome (ARDS) and/or mortality, in patients presenting to the hospital with suspicion or diagnosis of COVID-19. …

acute respiratory distress
covid-19
respiratory distress
  • 0 views
  • 16 Feb, 2024
  • 3 locations
Impact of Respiratory Virus in Critically Ill Patients With Acute Respiratory Failure

This is an observational study to evaluate the clinical impact of respiratory virus in the patients with acute respiratory failure

critically ill
respiratory failure
acute respiratory failure
critical illness
  • 0 views
  • 16 Feb, 2024
  • 1 location
Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic

Impacts of the Covid-19 epidemic and associated lockdown measures on the management, health and behaviors of cystic fibrosis patients during the 2020 epidemic

covid-19
fibrosis
cftr gene
cystic fibrosis
  • 0 views
  • 16 Feb, 2024
  • 3 locations
A Study of Patients With Chronic Disease

TARGET-RWE is a 10-year, international, longitudinal, observational study of patients with chronic disease designed to specifically address important clinical questions that remain incompletely answered from registration trials. The protocol will follow a master protocol design in which a shared study infrastructure supports progressive development of the registry across the spectrum …

chronic disease
a 10
  • 0 views
  • 16 Feb, 2024
  • 4 locations